PDS Biotechnology Corp - COM (PDSB)

Historical Portfolio Holders from Q1 2019 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
4.33M
Holdings value Q3 2024
$16.5M
Value change Q3 2024
-$3.54M
Grand Portfolio weight change Q3 2024
0%
Number of holders
56
Number of buys Q3 2024
14
Number of sells Q3 2024
-41
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 4.33M $16.5M -$3.54M $3.82 57
2024 Q2 5.49M $16.1M -$6.95M $2.93 73
2024 Q1 7.61M $30.1M -$4.11M $3.96 69
2023 Q4 8.19M $40.8M +$2.32M $4.97 72
2023 Q3 7.86M $39.7M -$404K $5.05 77
2023 Q2 7.93M $39.9M -$318K $5.03 79
2023 Q1 7.61M $46.8M +$1.17M $6.15 65
2022 Q4 6.82M $90M +$24M $13.20 63
2022 Q3 5.18M $15.4M -$459K $2.97 42
2022 Q2 5.25M $19.2M -$3.84M $3.65 46
2022 Q1 5.85M $36.2M -$1.23M $6.19 49
2021 Q4 5.92M $47.9M -$12.2M $8.10 63
2021 Q3 6.75M $101M +$11.3M $14.90 58
2021 Q2 5.94M $74.4M +$40.6M $12.55 41
2021 Q1 3.15M $14.3M +$1.35M $4.55 29
2020 Q4 3.13M $6.7M -$487K $2.14 25
2020 Q3 3.3M $7.68M +$3.73M $2.33 26
2020 Q2 1.7M $3.42M +$619K $2.01 18
2020 Q1 1.63M $1.18M +$762K $0.73 19
2019 Q4 540K $1.43M +$70.8K $2.65 15
2019 Q3 509K $1.72M +$122K $3.37 16
2019 Q2 461K $2.76M +$1.03M $5.99 16
2019 Q1 287K $2.12M +$2.12M $7.39 14